These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30511296)

  • 41. Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.
    Favalli EG; Conti F; Selmi C; Iannone F; Bucci R; D'Onofrio F; Carlino G; Santo L; Semeraro A; Zuccaro C; D'Angelo S; Atzeni F; Marino F; Monti S; Guidelli GM; Spinelli FR; Biggioggero M; Caporali R
    Clin Exp Rheumatol; 2020; 38(1):19-26. PubMed ID: 31074721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis: A Real-World Evidence Study With Ustekinumab.
    Queiro R; Brandy A; Rosado MC; Lorenzo A; Coto P; Carriles C; Alperi M; Ballina J
    J Clin Rheumatol; 2018 Oct; 24(7):381-384. PubMed ID: 29509560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.
    Gottlieb A; Gratacos J; Dikranian A; van Tubergen A; Fallon L; Emir B; Aikman L; Smith T; Chen L
    Rheumatol Int; 2019 Jan; 39(1):121-130. PubMed ID: 30426237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis.
    Sheane BJ; Thavaneswaran A; Gladman DD; Chandran V
    J Rheumatol; 2016 Sep; 43(9):1718-23. PubMed ID: 27422895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
    Queiro R; Cañete JD; Montilla C; Abad MA; Montoro M; Gómez S; Cábez A;
    J Rheumatol; 2019 Jul; 46(7):710-715. PubMed ID: 30709957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study.
    Perrotta FM; Lubrano E
    Postgrad Med; 2016 Sep; 128(7):693-6. PubMed ID: 27494077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis.
    Wervers K; Luime JJ; Tchetverikov I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Vis M;
    Arthritis Res Ther; 2019 Jan; 21(1):25. PubMed ID: 30651121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers.
    Iervolino S; Di Minno MN; Peluso R; Lofrano M; Russolillo A; Di Minno G; Scarpa R
    J Rheumatol; 2012 Mar; 39(3):568-73. PubMed ID: 22247361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA.
    Iannone F; Lopriore S; Bucci R; Scioscia C; Anelli MG; Notarnicola A; Lapadula G
    Scand J Rheumatol; 2015 May; 44(3):192-9. PubMed ID: 25564882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry.
    Lindström Egholm C; Krogh NS; Pincus T; Dreyer L; Ellingsen T; Glintborg B; Kowalski MR; Lorenzen T; Madsen OR; Nordin H; Rasmussen C; Hetland ML
    J Rheumatol; 2015 Oct; 42(10):1781-5. PubMed ID: 26233511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The current status and unmet needs in the management of psoriatic arthritis: Viewpoint from physicians in Taiwan.
    Li TH; Liao HT; Huang YF; Shen YC; Chiu YC; Chen WS; Chen MH; Tsai CY; Chang DM
    J Formos Med Assoc; 2018 May; 117(5):404-412. PubMed ID: 28552625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.
    Stekhoven D; Scherer A; Nissen MJ; Grobéty V; Yawalkar N; Villiger PM; Möller B;
    Clin Rheumatol; 2017 Sep; 36(9):2035-2043. PubMed ID: 28432523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate.
    Costa L; Lubrano E; Ramonda R; Chimenti MS; Vezzù M; Perrotta FM; Del Puente A; Peluso R; Bottiglieri P; Lorenzin M; Sunzini F; Darda MA; Fiocco U; Perricone R; Punzi L; Scarpa R; Caso F
    Clin Rheumatol; 2017 Aug; 36(8):1797-1802. PubMed ID: 28589323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in the patient's and the physician's perspective of disease in psoriatic arthritis.
    Dandorfer SW; Rech J; Manger B; Schett G; Englbrecht M
    Semin Arthritis Rheum; 2012 Aug; 42(1):32-41. PubMed ID: 22424812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
    Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
    Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement.
    van Mens LJJ; Turina MC; van de Sande MGH; Nurmohamed MT; van Kuijk AWR; Baeten DLP
    Rheumatology (Oxford); 2018 Feb; 57(2):283-290. PubMed ID: 28541484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients.
    Gazitt T; Elhija MA; Haddad A; Lavi I; Elias M; Zisman D
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries.
    Lucasson F; Kiltz U; Kalyoncu U; Leung YY; Palominos P; Cañete JD; Scrivo R; Balanescu A; Dernis E; Meisalu S; Ryussen-Witrand A; Soubrier M; Aydin SZ; Eder L; Gaydukova I; Lubrano E; Richette P; Husni E; Coates LC; de Wit M; Smolen JS; Orbai AM; Gossec L
    RMD Open; 2022 May; 8(1):. PubMed ID: 35523519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study.
    Caso F; Navarini L; Carubbi F; Picchianti-Diamanti A; Chimenti MS; Tasso M; Currado D; Ruscitti P; Ciccozzi M; Annarumma A; Laganà B; Perricone R; Afeltra A; Giacomelli R; Scarpa R; Costa L
    Rheumatol Int; 2020 Jun; 40(6):951-958. PubMed ID: 31605152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.